Drug profile · INN
sodium nitroprusside
SODIUM NITROPRUSSIDE
sodium nitroprusside (SODIUM NITROPRUSSIDE) is a soluble guanylate cyclase activator. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — sodium nitroprusside
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
sodium nitroprusside (SODIUM NITROPRUSSIDE) is a soluble guanylate cyclase activator. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Soluble guanylate cyclase activator
Primary target: Soluble guanylate cyclase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is sodium nitroprusside?
sodium nitroprusside (SODIUM NITROPRUSSIDE) is a soluble guanylate cyclase activator. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for sodium nitroprusside?
SODIUM NITROPRUSSIDE is a marketed brand name for sodium nitroprusside. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sodium nitroprusside?
sodium nitroprusside has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.